Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 46 non-cytoplasmic 47 67 transmembrane 68 78 cytoplasmic 79 102 transmembrane 103 150 non-cytoplasmic 151 170 transmembrane 171 186 cytoplasmic 187 209 transmembrane 210 226 non-cytoplasmic 227 247 transmembrane 248 300 cytoplasmic 301 323 transmembrane 324 326 cytoplasmic 327 342 transmembrane 343 345 non-cytoplasmic 346 347 transmembrane 348 352 non-cytoplasmic 353 377 transmembrane 378 441 cytoplasmic
Input: >HSERO_RS13105 MTAQKPPLYKSLYFQVLVAIVIGILLGHFYPSTGEAMKPLGDGFVKLIKMIIAPVIFCTV VIGIAGMEDMKKVGKTGGLALLYFEVVSTVALIIGLLLVNFLQPGVGMNVDPASLDTKSI AAYTAPGKMGSVTDFVLGIIPTSMVDAFAKGDVLQVLLVAVLFGFALHKFGGRGTLVFDF IEKISHVLFSVVGAIMKVAPIGAFGAMSFTIGKYGVGSLFSLAKLMGTFYLTCLLFIFVV LGIITRLHGFSIWKFVKYIKEELLIVLGTSSSESVLPRMLAKMENAGAKKTVVGLVIPTG YSFNLDGTAIYLTMAAVFIAQATNTPMTFVQELTLLGVLLLTSKGAAGITGSGFIVLAAT LSAVGHVPVAGLALILGIDRFMSEARALTNTIGNGVATLVVAKWSGELDSERLTKVLNNE TVEDAQAPESILDRTDAKMHH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server